Surgical Outcomes for Proliferative Diabetic Retinopathy by Preoperative Glycemic Control and Renal Function

Evaluation of 25-gauge Vitrectomy Surgical Outcomes for Proliferative Diabetic Retinopathy by Preoperative Glycemic Control and Renal Function

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03522311

Enrollment

251

Registered

2018-05-11

Start date

2013-01-31

Completion date

2016-10-31

Last updated

2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Proliferative Diabetic Retinopathy

Brief summary

The surgical outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy has been evaluated by preoperative glycemic control and renal function

Detailed description

The purpose of this study is to evaluate the surgical outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy by preoperative glycemic control and renal function.

Interventions

PROCEDUREVitrectomy

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

10 Years to 90 Years

Healthy volunteers

Inclusion criteria

* The patients had25-gauge vitrectomy for proliferative diabetic retinopathy

Exclusion criteria

* The patients had hemodialysis , followed up less than 6 months, had vitrectomy for diabetic macular edema and macular ration but not macular detachment.

Design outcomes

Primary

Measure	Time frame	Description
Visual acuity measurement	6 months	Visual acuity improvement from baseline

Secondary

Measure	Time frame	Description
Presence of postoperative vitreous hemorrhage	6 months	Incidence of postoperative vitreous hemorrhage

Other

Measure	Time frame	Description
Presence of postoperative retinal detachment	6 months	Incidence of postoperative retinal detachment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026